Non-invasive diagnosis of pulmonary hypertension;Nicht-invasive Diagnostik der pulmonalen Hypertonie

Deutsche Medizinische Wochenschrift

Volumn 135, Issue SUPPL. 3, 2010, Pages

  Grünig, Ekkehard ^a   Barner, A ^b   Bell, M ^c   Claussen, M ^d   Dandel, M ^e   Dumitrescu, D ^f   Gorenflo, M ^g   Holt, S ^h   Kovacs, G ⁱ   Ley, S ^j   Meyer, J F ^k   Pabst, S ^l   Riemekasten, G ^m   Saur, J ⁿ   Schwaiblmair, M ^o   Seck, C ^f   Sinn, L ^p   Sorichter, S ^q   Winkler, J ^r   Leuchte, H H ^s  

^a Thoraxklinik Heidelberg   (Germany)

^b KLINIKUM FÜRTH   (Germany)

^c ELISABETH KRANKENHAUS ESSEN   (Germany)

^d Abteilung Pneumologie   (Germany)

^e DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h RUHR UNIVERSITY BOCHUM   (Germany)

ⁱ UNIVERSITY HOSPITAL GRAZ   (Austria)

^j UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^k Stadtisches Kronkenhous Harlaching   (Germany)

^l UNIVERSITY HOSPITAL BONN   (Germany)

^m CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁿ UNIVERSITY OF HEIDELBERG   (Germany)

^o KLINIKUM AUGSBURG   (Germany)

^p Kardiologische Praxis   (Germany)

^q UNIVERSITY OF FREIBURG   (Germany)

^r Pneumologische Praxis   (Germany)

^s Krankenhaus Neuwittelsbach   (Germany)

more..

Author keywords

pulmonary hypertension diagnosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; TROPONIN I; TROPONIN T;

CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAM; HUMAN; LUNG FUNCTION; LUNG VENTILATION PERFUSION RATIO; PRACTICE GUIDELINE; PULMONARY HYPERTENSION; SPIROMETRY; STRESS ECHOCARDIOGRAPHY; SYMPTOM; THORAX RADIOGRAPHY; ALGORITHM; CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; GERMANY; HYPERTENSION, PULMONARY; MEDICAL SOCIETY; PREDICTIVE VALUE;

ALGORITHMS; EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; HYPERTENSION, PULMONARY; PREDICTIVE VALUE OF TESTS; SOCIETIES, MEDICAL;

EID: 77957373339     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0030-1263314     Document Type: Conference Paper

References (67)

1. Rich S, Dantzker D R., Ayres S M. et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987 107 216-223 (Pubitemid 17137857)
2. Gaine S P., Rubin L J. Primary pulmonary hypertension. Lancet 1998 352 719-725 (Pubitemid 28398718)
3. Tongers J, Schwerdtfeger B, Klein G et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007 153 127-132 (Pubitemid 44889238)
4. Hoeper M M., Pletz M W., Golpon H, Welte T. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2007 29 944-950 (Pubitemid 46711899)
5. Badesch D B., Champion H C., Sanchez M A. et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009 54 S55-66
6. Fisher M R., Criner G J., Fishman A P. et al. Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur Respir J 2007 30 914-921
7. Hachulla E, Gressin V, Guillevin L et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005 52 3792-3800 (Pubitemid 41798217)
8. Mukerjee D, St George D, Knight C et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 2004 43 461-466 (Pubitemid 38489363)
9. Launay D, Mouthon L, Hachulla E et al. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol 2007 34 1005-1011 (Pubitemid 46774846)
10. Sitbon O, Lascoux-Combe C, Delfraissy J F. et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 2008 177 108-113
11. Rudski L G., Lai W W., Afilalo J et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010 23 685-713; 786788
12. Bonderman D, Wexberg P, Martischnig A et al. A non-invasive algorithm to exclude precapillary pulmonary hypertension. Eur Respir J 2010 in press
13. Tunariu N, Gibbs S J., Win Z et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007 48 680-684 (Pubitemid 47604965)
14. Resten A, Maitre S, Humbert M et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. Am J Roentgenol 2004 183 65-70 (Pubitemid 38789013)
15. Dartevelle P, Fadel E, Mussot S et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004 23 637-648 (Pubitemid 38456010)
16. Reichelt A, Hoeper M M., Galanski M et al. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angio-graphy. Eur J Radiol 2009 71 49-54
17. Fedullo P F., Auger W R., Kerr K M. et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001 345 1465-1472
18. Marcus J T., Gan C T., Zwanenburg J J. et al. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol 2008 51 750-757
19. Torbicki A. Cardiac magnetic resonance in pulmonary arterial hypertension, a step in the right direction. Eur Heart J 2007 28 1187-1189 (Pubitemid 47343839)
20. Rich S, Kieras K, Groves B et al. Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 1986 8 1307-1311 (Pubitemid 17208906)
21. Chu J W., Kao P N., Faul J L. et al. High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest 2002 122 1668-1673 (Pubitemid 35366080)
22. Albrecht T, Blomley M J., Cosgrove D O. et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999 353 1579-1583 (Pubitemid 29219208)
23. Naeije R. Hepatopulmonary syndrome and portopulmonary hypertension. Swiss Med Wkly 2003 133 163-169 (Pubitemid 36628590)
24. DAlonzo G E., Barst R J., Ayres S M. et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991 115 343-349
25. Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS ATS statement: Guidelines for the six minute walk test. Am J Respir Crit Care Med 2002 166 111-117
26. Miyamoto S, Nagaya N, Satoh T et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000 161 487-492 (Pubitemid 30129457)
27. Sitbon O, Humbert M, Nunes H et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002 40 780-788 (Pubitemid 34925627)
28. Paciocco G, Martinez F, Bossone E et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001 17 647-652 (Pubitemid 32492552)
29. Oudiz R J., Barst R J., Hansen J E. et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 2006 97 123-126 (Pubitemid 41828135)
30. Wensel R, Opitz C F., Anker S D. et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002 106 319-324 (Pubitemid 34778955)
31. Ross R M. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003 167 1451
32. Palange P, Ward S A., Carlsen K H. et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007 29 185-209 (Pubitemid 46092015)
33. Yasunobu Y, Oudiz R J., Sun X G. et al. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005 127 1637-46 (Pubitemid 46218789)
34. Tolle J J., Waxman A B., Van Horn T L. et al. Exercise-induced pulmonary arterial hypertension. Circulation 2008 118 2183-2189
35. Sun X G., Hansen J E., Oudiz R J., Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001 104 429-435 (Pubitemid 32678273)
36. Groepenhoff H, Vonk-Noordegraaf A, Boonstra A et al. Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc 2008 40 1725-1732
37. Bonow R O., Carabello B A., Kanu C et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006 114 e84-231
38. Kovacs G, Maier R, Aberer E et al. Assessment of pulmonary arteriel pressure during exercise in collagen vascular disease: echocardiography versus right heart catheterisation (in press). Chest 2010; in press
39. Himelman R B., Stulbarg M, Kircher B et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease. Circulation 1989 79 863-871 (Pubitemid 19100546)
40. Argiento P, Chesler N, Mule M. Exercise stress echocardiography for the study of the pulmonary circulation. Eur Respir J 2010 35 1273-1278
41. Grunig E, Weissmann S, Ehlken N et al. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia. Circulation 2009 119 1747-1757
42. Grunig E, Janssen B, Mereles D et al. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 2000 102 1145-1150
43. Alkotob M L., Soltani P, Sheatt M A. et al. Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma. Chest 2006 130 176-181 (Pubitemid 44116857)
44. Collins N, Bastian B, Quiqueree L et al. Abnormal pulmonary vascular responses in patients registered with a systemic autoimmunity database: Pulmonary Hypertension Assessment and Screening Evaluation using stress echocardiography (PHASE-I). Eur J Echocardiogr 2006 7 439-446 (Pubitemid 44645060)
45. Pignone A, Mori F, Pieri F et al. Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci 2007 1108 291-304 (Pubitemid 47528742)
46. Callejas-Rubio J L., Moreno-Escobar E, de la Fuente P M. et al. Prevalence of exercise pulmonary arterial hypertension in scleroderma. J Rheumatol 2008 35 1812-1816 (Pubitemid 351655805)
47. Steen V, Chou M, Shanmugam V et al. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 2008 134 146-151 (Pubitemid 352008776)
48. Condliffe R, Kiely D G., Peacock A J. et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009 179 151-157
49. Kovacs G, Maier R, Aberer E et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med 2009 180 881-886
50. Voelkel M A., Wynne K M., Badesch D B. et al. Hyperuricemia in severe pulmonary hypertension. Chest 2000 117 19-24
51. Nagaya N, Nishikimi T, Uematsu M et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000 102 865-870
52. Williams M H., Handler C E., Akram R et al. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 2006 27 1485-1494 (Pubitemid 43998084)
53. Fijalkowska A, Kurzyna M, Torbicki A et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006 129 1313-1321
54. Andreassen A K., Wergeland R, Simonsen S et al. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Am J Cardiol 2006 98 525-529 (Pubitemid 44162883)
55. Torbicki A, Kurzyna M, Kuca P et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003 108 844-848 (Pubitemid 37022127)
56. Leuchte H H., Baumgartner R A., Nounou M E. et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006 173 744-750
57. McLaughlin V V., McGoon M D. Pulmonary arterial hypertension. Circulation 2006 114 1417-1431 (Pubitemid 44454562)
58. Eysmann S B., Palevsky H I., Reichek N et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989 80 353-360 (Pubitemid 19195745)
59. Raymond R J., Hinderliter A L., Willis P W. et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002 39 1214-1219
60. Forfia P R., Fisher M R., Mathai S C. et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006 174 1034-1041
61. Tei C, Dujardin K S., Hodge D O. et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 1996 9 838-847
62. Yeo T C., Dujardin K S., Tei C et al. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol 1998 81 1157-1161 (Pubitemid 28232689)
63. Nir A, Lindinger A, Rauh M et al. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009 30 3-8
64. Koestenberger M, Ravekes W, Everett A D. et al. Right ventricular function in infants, children and adolescents: Reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values. J Am Soc Echocardiogr 2009 22 715-719
65. Galie N, Hoeper M M., Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009 34 1219-1263
66. Galie N, Hoeper M M., Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009 30 2493-2537
67. Hoeper M M., Ghofrani H A., Gorenflo M et al. Diagnostik und Therapie der pulmonalen Hypertonie: Europäische Leitlinie 2009. Pneumologie 2010 64 401-414